Longitudinal studies and functional assays could help clarify whether CAP1 and CAPZB play a causal role in HD pathophysiology or represent a downstream consequence of broader cellular dysfunction, which may be translated to the clinic for diagnostic and prognostic purposes. This evidence concerns the gene CAPZB and Huntington disease.